Full Text View
Tabular View
No Study Results Posted
Related Studies
Validation of Brain Oxygenation Monitor on Pediatric Patients
This study is currently recruiting participants.
Study NCT00849940   Information provided by Duke University
First Received: January 22, 2009   Last Updated: February 22, 2009   History of Changes

January 22, 2009
February 22, 2009
February 2009
December 2009   (final data collection date for primary outcome measure)
Accuracy of device to measure cerebral tissue oxygen saturation [ Time Frame: One day ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00849940 on ClinicalTrials.gov Archive Site
 
 
 
Validation of Brain Oxygenation Monitor on Pediatric Patients
Validation of the CAS Medical System, Inc. FORE-SIGHT Near-Infrared Spectroscopy (NIRS) Monitor in Pediatric Subjects for Viscerosomatic Applications

The aim of this study is calibrate (adjust and tune) the CAS FORE-SIGHT Near-Infrared Spectroscopy (NIRS) monitor when used to measure the tissue oxygen saturation of internal organs (StO2). This is a measure of the amount of oxygen carried by the blood within the internal organs. In addition the study will assess the degree of similarities between StO2 and mean mixed venous oxygen saturation - a measure of the amount of oxygen carried in the blood returning to the heart.

NIRS cerebral oximeters are FDA-approved devices used to measure oxygen saturation within the brain, in a similar manner to pulse oximeters that measure the oxygen saturation in the finger tip. The sensor pads are placed on the surface of the forehead and shine near-infrared light through the skull and brain tissue from which the brain tissue oxygen saturation is estimated. The same principles can be applied when the sensor pads are placed over the internal organs of the abdomen, for example, the liver. Currently the only way to accurately measure the oxygen saturation of internal organs is by the invasive placement of intravenous lines into the blood vessels of that organ. This study will determine if the NIRS sensors can reliably estimate the tissue oxygen saturation non-invasively by placing the pad over the skin of the abdomen.

The study will be conducted in pediatric patients who are undergoing cardiac catheterization, a procedure in which invasive lines are placed in order to get information about the heart. The procedure is always conducted under general anesthesia. During the cardiac catheterization procedure blood samples are routinely taken for oxygen saturation analysis. In the study two oximeter sensor pads will be placed on the forehead (one on each side) and two further oximeter sensor pads will be placed on the abdominal wall. The oxygen saturation values from all oximeter sensors will be recorded continuously throughout the cardiac catheterization procedure and will be compared to the oxygen saturation values from the blood samples. In addition to the routine blood samples taken as part of the cardiac catheterization, one blood sample will be taken when the invasive line is within the right hepatic (liver) vein.

The information from this study will determine how well the oximeter sensors estimate the oxygen saturation of both the internal organs (StO2) and the blood returning to the heart (mean mixed venous oxygen saturation).

 
Interventional
Intervention Model:  Single Group Assignment
Masking:  Open Label
Primary Purpose:  Diagnostic
Cardiac Catheterization
Device: CAS NIRS FORE-SIGHT oximeter
Comparison of non-invasive tissue oxygen saturation with blood sample-derived (calculated) tissue oxygen saturation.
Other Name: CAS NIRS FORE-SIGHT oximeter
1: Experimental
Pediatric patients presenting for cardiac catheterization.
Intervention: Device: CAS NIRS FORE-SIGHT oximeter
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
65
December 2009
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • ≤ 18 years old
  • ≥ 2.5 kg and ≤ 40 kg weight
  • Undergoing cardiac catheterization at Duke pediatric cardiac catheterization laboratory

Exclusion Criteria:

  • Known structural neurologic or craniofacial disease
  • Arterial catheter placement not part of planned catheterization procedure
  • Anemia (hemoglobin < 10 g/dl)
Both
up to 17 Years
No
Contact: Richard Ing, MB BCh, FCA 919-681-3551 richard.ing@duke.edu
Contact: Sonya K Capps 919-812-5043 sonya.capps@duke.edu
United States
 
NCT00849940
Dr. Richard Ing, Duke University Medical Center
Duke-9391
Duke University
CAS Medical Systems, Inc.
Principal Investigator: Richard Ing, MB BCh, FCA Duke University Health System
Duke University
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP